Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Effectiveness of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women.

Mlugu EM, Minzi O, Asghar M, Färnert A, Kamuhabwa AAR, Aklillu E.

Pathogens. 2020 Mar 11;9(3). pii: E207. doi: 10.3390/pathogens9030207.

2.
3.

Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania.

Mnkugwe RH, Minzi OS, Kinung'hi SM, Kamuhabwa AA, Aklillu E.

PLoS One. 2020 Feb 5;15(2):e0228770. doi: 10.1371/journal.pone.0228770. eCollection 2020.

4.

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania.

Mnkugwe RH, Minzi OS, Kinung'hi SM, Kamuhabwa AA, Aklillu E.

Pathogens. 2019 Dec 27;9(1). pii: E28. doi: 10.3390/pathogens9010028.

5.

Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations.

Mutagonda RF, Minzi OMS, Massawe SN, Asghar M, Färnert A, Kamuhabwa AAR, Aklillu E.

Drug Metab Dispos. 2019 Dec;47(12):1415-1424. doi: 10.1124/dmd.119.088062.

PMID:
31744845
6.
7.

Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.

Mikomangwa WP, Oms M, Aklillu E, Kamuhabwa AAR.

BMC Pregnancy Childbirth. 2019 Jul 8;19(1):236. doi: 10.1186/s12884-019-2397-1.

8.

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.

Mutagonda RF, Kamuhabwa AAR, Minzi OMS, Massawe SN, Asghar M, Homann MV, Färnert A, Aklillu E.

Malar J. 2017 Jul 3;16(1):267. doi: 10.1186/s12936-017-1914-9.

9.

Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.

Kamuhabwa AA, Gordian R, Mutagonda RF.

Drug Healthc Patient Saf. 2016 Dec 13;8:91-100. doi: 10.2147/DHPS.S119073. eCollection 2016.

10.

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.

Mutagonda RF, Kamuhabwa AA, Minzi OM, Massawe SN, Maganda BA, Aklillu E.

Malar J. 2016 May 13;15(1):278. doi: 10.1186/s12936-016-1327-1.

11.

Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities.

Kamuhabwa AA, Manyanga V.

Drug Healthc Patient Saf. 2015 Oct 29;7:147-56. doi: 10.2147/DHPS.S89115. eCollection 2015.

12.

CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.

Maganda BA, Minzi OM, Ngaimisi E, Kamuhabwa AA, Aklillu E.

Pharmacogenomics J. 2016 Feb;16(1):88-95. doi: 10.1038/tpj.2015.37. Epub 2015 May 12.

PMID:
25963334
13.
14.

Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.

Maganda BA, Minzi OM, Kamuhabwa AA, Ngasala B, Sasi PG.

Malar J. 2014 May 30;13:205. doi: 10.1186/1475-2875-13-205.

15.

Knowledge among drug dispensers and antimalarial drug prescribing practices in public health facilities in Dar es Salaam.

Kamuhabwa AA, Silumbe R.

Drug Healthc Patient Saf. 2013 Sep 2;5:181-9. doi: 10.2147/DHPS.S50071. eCollection 2013.

16.

Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder.

Kamuhabwa AA, Di Mavungu JD, Baert L, D'Hallewin MA, Hoogmartens J, de Witte PA.

Eur J Pharm Biopharm. 2005 Apr;59(3):469-74.

PMID:
15760727
17.

Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.

Kamuhabwa AA, Huygens A, De Witte PA.

Int J Oncol. 2003 Nov;23(5):1445-50.

PMID:
14532989
18.

Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.

Kamuhabwa AA, Roskams T, D'Hallewin MA, Baert L, Van Poppel H, de Witte PA.

Int J Cancer. 2003 Nov 10;107(3):460-7.

19.

Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.

Kamuhabwa AA, Roskams T, Baert L, De Witte PA.

Int J Oncol. 2003 Apr;22(4):933-7.

PMID:
12632090
20.

Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.

Kamuhabwa AA, Cosserat-Gerardin I, Didelon J, Notter D, Guillemin F, Roskams T, D'Hallewin MA, Baert L, de Witte PA.

Int J Cancer. 2002 Jan 10;97(2):253-60.

Supplemental Content

Loading ...
Support Center